Bacil Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	5.69	28.57	0.41	0.29	2.3
Trading Asset Securities	-	-	-	1.91	0.76
Cash & Short-Term Investments	5.69	28.57	0.41	2.2	3.06
Cash Growth	-80.10%	6788.85%	-81.12%	-28.26%	28.71%
Accounts Receivable	11.8	-	-	-	-
Receivables	11.8	-	-	-	-
Other Current Assets	0.05	0.5	0.11	0.09	0.1
Total Current Assets	17.53	29.07	0.52	2.29	3.16
Property, Plant & Equipment	-	-	0.06	0.08	0.11
Long-Term Investments	242.4	213.57	6.11	2.36	2.36
Long-Term Deferred Tax Assets	6.19	0.54	0.56	1.17	1.08
Other Long-Term Assets	-0	0	-	0	-0
Total Assets	273.93	256	13.26	11.27	12.72
Accounts Payable	0.2	0.04	0.04	0	0.11
Accrued Expenses	23.81	-	0.09	0.06	0.02
Short-Term Debt	-	1.64	0.98	0.21	0.33
Other Current Liabilities	1.8	0.01	0.02	0.01	0.02
Total Current Liabilities	25.8	1.69	1.13	0.28	0.47
Other Long-Term Liabilities	-0	0	-	0	-
Total Liabilities	25.8	1.69	1.13	0.28	0.47
Common Stock	139.7	139.7	58.9	58.9	58.9
Retained Earnings	108.42	114.61	-53.14	-54.28	-53.03
Comprehensive Income & Other	-	-	6.37	6.37	6.37
Shareholders' Equity	248.13	254.31	12.13	10.99	12.24
Total Liabilities & Equity	273.93	256	13.26	11.27	12.72
Total Debt	-	1.64	0.98	0.21	0.33
Net Cash (Debt)	5.69	26.93	-0.57	1.99	2.73
Net Cash Growth	-78.89%	-	-	-27.11%	338.69%
Net Cash Per Share	0.41	4.27	-0.10	0.33	0.46
Filing Date Shares Outstanding	14.13	14.35	5.89	5.89	5.89
Total Common Shares Outstanding	14.13	14.35	5.89	5.89	5.89
Working Capital	-8.27	27.39	-0.61	2.01	2.69
Book Value Per Share	17.56	17.72	2.06	1.87	2.08
Tangible Book Value	248.13	254.31	12.13	10.99	12.24
Tangible Book Value Per Share	17.56	17.72	2.06	1.87	2.08
Machinery	-	0.59	0.55	0.59	0.59